Founded in New York City, INNOVATE Corp., formerly known as HC2, Inc., is a diversified holding company with a core mission to invest in and develop high-potential businesses across various sectors. The company's vision is to drive innovation and growth in infrastructure, life sciences, and broadcasting assets globally. Their portfolio includes DBM Global, the largest steel fabrication and erection company in the U.S., Pansend Life Sciences, which focuses on developing groundbreaking healthcare technologies, and R2 Technologies, known for its FDA-cleared dermatological devices.
Notable affiliated individuals include the company's leadership team, who bring extensive experience in finance and strategic investments. INNOVATE Corp. has attracted significant investment from prominent financial entities, bolstering its capacity to scale its operations. Key achievements include the breakthrough device designation from the FDA for MediBeacon's real-time kidney function monitoring technology. Overall, INNOVATE Corp. has made a substantial impact by fostering innovation and addressing unmet needs in critical industries.
